誉衡药业涨停 2025年净利润预计增长50.37%—80.44%

Core Viewpoint - The stock price of Yuheng Pharmaceutical has experienced significant movement, reaching the daily limit with a trading volume of 48.37 million shares and a transaction amount of 166 million yuan, following the release of its latest earnings forecast for 2025, which indicates a projected net profit of 350 million to 420 million yuan, representing a year-on-year growth of 50.37% to 80.44% [2] Group 1: Stock Performance - As of 9:31 AM today, Yuheng Pharmaceutical's stock price hit the daily limit with a trading volume of 48.37 million shares and a transaction amount of 166 million yuan, resulting in a turnover rate of 2.30% [2] - The stock's limit-up order amount reached 793 million yuan, indicating strong investor interest [2] - Among companies that announced their 2025 earnings forecasts today, Yuheng Pharmaceutical's stock price increased by 10.03%, reflecting a robust market response [2] Group 2: Financial Data - The latest earnings forecast for Yuheng Pharmaceutical anticipates a net profit of 350 million to 420 million yuan for 2025, with a year-on-year growth rate between 50.37% and 80.44% [2] - Over the past five days, the main funds for Yuheng Pharmaceutical have shown a net outflow of 36.97 million yuan, with a significant outflow of 23.80 million yuan on the previous trading day [2] - The latest margin trading data indicates that the total margin balance for Yuheng Pharmaceutical is 316 million yuan, with a decrease of 11.11 million yuan in the financing balance over the past five days, representing a decline of 3.39% [2]